• Published in Patient Preference and Adherence – 2022

  • Collaborator: Janssen Global

  • Authors: Joyce LaMori, Antoine Seignez, Lise Radoszycki

Human immunodeficiency virus (HIV)-1 infection remains a concern. As patient adherence to antiretroviral therapy is essential to avoid drug resistance and virologic failure, greater understanding of patient treatment satisfaction may help facilitate ongoing medication use.
This descriptive study assessed patient satisfaction with DRV/c/FTC/TAF and HIV-related symptoms at baseline and follow-up (4– 6 weeks).